Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials

Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials

Mei Zhao,1 Xiaohong Zhang,1 Dongyang Zhou,2 Junxian Song3– 5 1Department of Pharmacy, Peking University People’s Hospital, Beijing, People’s Republic of China; 2Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK; 3Department of Cardiology,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhao M, Zhang X, Zhou D, Song J
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-01-01
Series:	Open Access Journal of Clinical Trials
Subjects:	anthracycline-induced cardiotoxicity clinical trials cardiovascular toxicity cancer therapy safety
Online Access:	https://www.dovepress.com/advancements-in-managing-anthracycline-induced-cardiotoxicity-insights-peer-reviewed-fulltext-article-OAJCT
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Early Myocardial Strain Reduction and miR-122-5p Elevation Associated with Interstitial Fibrosis in Anthracycline-Induced Cardiotoxicity
by: María de Regla Caballero-Valderrama, et al.
Published: (2024-12-01)

Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
by: Koichi Egashira, et al.
Published: (2022-06-01)

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
by: Marijke Linschoten, et al.
Published: (2025-01-01)

A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients
by: Bo Dai, et al.
Published: (2025-01-01)

Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer
by: Tytti-Maria Uurasmaa, et al.
Published: (2025-01-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Assessment of Hsp90β-selective inhibitor safety and on-target effects
by: Tyelor S. Reynolds, et al.
Published: (2025-01-01)

Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
by: Xiang Zhang, et al.
Published: (2025-02-01)

Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review
by: Irene Cartas‐Espinel, et al.
Published: (2022-06-01)

Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor
by: Yuting Wu, et al.
Published: (2025-02-01)

Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study
by: Xinye Li, et al.
Published: (2025-03-01)

Analysis of the cardiotoxic and myorelaxant effects of camphor on fish of the Nile tilapia species (Oreochromis niloticus) (Linnaeus 1758)
by: Clarissa Araújo da Paz, et al.
Published: (2025-01-01)

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Cardiotoxicity of polystyrene nanoplastics and associated mechanism of myocardial cell injury in mice
by: Ziyi Xiong, et al.
Published: (2025-01-01)

Evaluation of miR-146a as a potential biomarker for diagnosis of cardiotoxicity induced by chemotherapy in patients with breast cancer
by: Nasrin Zare, et al.
Published: (2025-01-01)

The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity
by: Daniela Di Lisi, et al.
Published: (2022-06-01)

Integrated Microbiome and Metabolome Analysis Reveals Correlations Between Gut Microbiota Components and Metabolic Profiles in Mice With Mitoxantrone-Induced Cardiotoxicity
by: Zhang Q, et al.
Published: (2025-01-01)

Distribution of trial registry numbers within full-text of PubMed Central articles: implications for linking trials to publications and indexing trial publication types
by: Arthur M. Holt, et al.
Published: (2025-01-01)

Osilodrostat treatment in patients with Cushing’s disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)
by: Akira Shimatsu, et al.
Published: (2024-12-01)

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
by: Xingpeng Di, et al.
Published: (2025-01-01)

Discrepancies in safety reporting for chronic back pain clinical trials: an observational study from ClinicalTrials.gov and publications
by: Nick Boyne, et al.
Published: (2025-02-01)

UK cancer vaccine advance – Recognising and realising opportunities
by: Charles Craddock, et al.
Published: (2025-01-01)

Predicting accrual success for better clinical trial resource allocation
by: Sisi Ma, et al.
Published: (2025-01-01)

Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin
by: Craig A. Swearingen, et al.
Published: (2025-01-01)

A maturity model for Clinical Trials Management Ecosystem
by: Shruti Sehgal, et al.
Published: (2025-01-01)

Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01)

Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatment
by: Juliana V. Costa, et al.
Published: (2025-01-01)

Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
by: Alessandra Cuomo, et al.
Published: (2022-06-01)

Quality of reporting in abstracts of clinical trials using physical activity interventions: a cross-sectional analysis using the CONSORT for Abstracts
by: Angélica Trevisan De Nardi, et al.
Published: (2023-10-01)

Prognosis and cardiotoxicity associated to adjuvant trastuzumab for breast cancer: real world study in a public health system
by: Ana Elisa Ribeiro da Silva Cabello, et al.
Published: (2025-01-01)

Publication of studies registered in Clinical Trials Registry of India: An audit of mood disorder research protocols from 2009-2019
by: Vikas Menon, et al.
Published: (2023-01-01)

Discrepancies in reported results between trial registries and journal articles for AI clinical researchResearch in context
by: Zixuan He, et al.
Published: (2025-02-01)

A multicenter retrospective study of early cardiac toxicity in operable breast cancer patients receiving concurrent dual or mono anti-HER2 therapy with postoperative radiation therapy
by: Jing Yang, et al.
Published: (2025-02-01)

Clinical trials to gene therapy development and production in Brazil: a review
by: Jonas Alex Morales Saute, et al.
Published: (2025-03-01)

Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe
by: Emilijus Žilinskas, et al.
Published: (2024-03-01)

Safety, Tolerability, and Pharmacokinetics of NIM‐1324 an Oral LANCL2 Agonist in a Randomized, Double‐Blind, Placebo‐Controlled Phase I Clinical Trial
by: Andrew Leber, et al.
Published: (2025-01-01)

Validation of the Food Safe Zone questionnaire for families of individuals with Prader-Willi syndrome
by: Elisabeth M. Dykens, et al.
Published: (2025-02-01)

Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
by: Qi Xu, et al.
Published: (2024-10-01)

The Role of Advanced Cardiac Imaging in Monitoring Cardiovascular Complications in Patients with Extracardiac Tumors: A Descriptive Review
by: Annamaria Tavernese, et al.
Published: (2024-12-01)